URGN UroGen Pharma Ltd. logo

URGN UroGen Pharma Ltd.

Healthcare
$28.89-3.31%ClosedMarket Cap: $1.41B

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

5

Dispositions

6

Buy/Sell Ratio

0.83

Net Shares

+45,236

Shares Acquired

65,942

Shares Disposed

20,706

Total Bought ($)

$0.00

Total Sold ($)

$3.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon May 11Schoenberg Markofficer: Chief Medical OfficerSell10,000$30.00134,985
Fri Feb 27Robinson James A. Jr.directorSell2,000$0.004,000
Thu Feb 19Barrett Elizabeth A.officer: Chief Executive OfficerSell153,195$0.00153,195
Wed Feb 11Smith Jason Drewofficer: General CounselSell3,217$19.6955,588
Wed Feb 11Smith Jason Drewofficer: General CounselSell2,654$19.6952,934
Wed Feb 11Smith Jason Drewofficer: General CounselSell1,608$19.6951,326
Wed Feb 11Smith Jason Drewofficer: General CounselSell6,667$0.0049,972
Wed Feb 11Smith Jason Drewofficer: General CounselSell5,500$0.0055,472
Wed Feb 11Smith Jason Drewofficer: General CounselSell3,333$0.0058,805
Wed Feb 11Smith Jason Drewofficer: General CounselSell32,609$0.0032,609